Volume 30, Issue 4 (Januray 2024)                   J Birjand Univ Med Sci. 2024, 30(4): 371-376 | Back to browse issues page

Research code: 456442
Ethics code: R.BUMS.REC.1400.153


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Naimi F, Allahyari E, Mortazavi Moghaddam S G. The first hospitalization after recovery from COVID-19 and its relationship with Remdesivir treatment: Short Communication. J Birjand Univ Med Sci. 2024; 30 (4) :371-376
URL: http://journal.bums.ac.ir/article-1-3360-en.html
1- Physician, Birjand University of Medical sciences, Vali-e-asrhospital, Birjand, Iran
2- Department of Epidemiology and Biostatistics, School of Health, Social Determinants of Health Research Center, Birjand University of Medical sciences, Birjand, Iran
3- Department of Internal Medicine (Pulmonary Diseases), School of Medicine, Infectious Diseases Research Center, Birjand University of Medical sciences, Birjand, Iran , gmortazavi@yahoo.com
Abstract:   (227 Views)
With the emergence of Corona disease in late 2019, the healthcare network was directly and indirectly affected, and the process and management of patients other than COVID-19 changed. To evaluate some of these changes, the present study was conducted on post-COVID-19 hospital admissions of patients who have been infected with Coronavirus in the past. The census method was used for patients’ recruitment. The collected data was analyzed using descriptive/analytical statistical methods. A total of 202 patients with a mean age of (57.60±18.73) years, including 109 (54%) women and 93 (46%) men, were recruited. The number and percentage of cases admitted in internal, infectious, neurology, and heart wards, were 63 (31%), 52 (25.7%), 35 (17.3%), and 31 (15.3%), respectively. No correlation was found between the history of hospitalization and the type of treatment specific to COVID-19 (Remdesivir) and the disease that led to re-hospitalization after recovery from COVID-19 (P=0.08). Regardless of whether receiving Remdesivir or not, post-COVID-19 hospitalization due to various reasons in internal and infectious wards was the most frequent, respectively, followed by cardiovascular events.
 

*Corresponding Author: Sayyed Gholamreza Mortazavi MoghaddamEmails: gmortazavi@yahoo.com

View ORCID iD Profile

You can also search for this author in:  PubMed     ResearchGate   Scopus    Google Scholar    Google Scholar Profile

Full-Text [PDF 432 kb]   (80 Downloads)    
Type of Study: Short Communication | Subject: Epidemiology
Received: 2023/12/9 | Accepted: 2024/01/27 | ePublished: 2024/02/4

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Birjand University of Medical Sciences

Designed & Developed by : Yektaweb